Closure of the Patent Foramen Ovale The End of the Sound and Vision Era Approaching⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Intervention or the American College of Cardiology. by Meier, Bernhard
EC
F
T
V
B
B
W
o
B
t
I
T
c
t
(
n
h
w
h
C
c
t
t
g
A
t
s
H
u
i
u
A
l
c
s
e
m
m
t
f
a
a
a
u
p
a
i
g
d
f
H
o
u
F
a
a
m
t
*
a
t
M
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 1 , N O . 4 , 2 0 0 8
© 2 0 0 8 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / 0 8 / $ 3 4 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 0 8 . 0 6 . 0 0 1DITORIAL COMMENT
losure of the Patent
oramen Ovale
he End of the Sound and
ision Era Approaching*
ernhard Meier, MD, FACC
ern, Switzerland
e have seen it before and we will see it again: a new pair
f trousers is at first worn only with a belt and suspenders.
ut after wearing them for a while and never losing them,
he suspenders are disposed of and only the belt remains.
nterventional cardiology offers several examples of this.
he abandoned temporary pacemaker for percutaneous
oronary angioplasty and echocardiography for balloon mi-
ral valvuloplasty are just 2 of them.
See page 387
The act of percutaneously closing a patent foramen ovale
PFO) may be accomplished in as little as 10 min from the
eedle puncture of the femoral vein to the patient putting
is finger on the groin while the sheath is removed and then
alking out of the catheterization laboratory, as would
appen after donating a pint of blood at a Red Cross station.
omplications are exceedingly rare with the belt (fluoros-
opy) alone (1–3). The paper of Hildick-Smith et al. (4) in
his issue of JACC: Cardiovascular Interventions deals with
he question whether and when suspenders (echocardio-
raphic guidance) might still be needed or recommended.
nd then again, it does not. It convincingly shows that, in
he majority of consecutive patients, the omission of ultra-
ound guidance did not impair the result of PFO closure.
owever, it does not provide evidence about whether
ltrasound guidance did improve the results in the minority
n whom it was used.
Arguments in favor or disfavor of using intraoperative
ltrasound during PFO closures are depicted in Table 1.
lthough not all of the arguments in favor can be discarded
ightly, it can be foretold that the more common PFO
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ion or the American College of Cardiology.
From the Cardiovascular Department, University Hospital, Bern, Switzerland. Dr.
eier has received research grants and is on the Speakers’ Bureau of AGA Medical.losure will become, the more the procedure will have to be
implified. The risk of suboptimal placement or device
mbolization is extremely small if the fluoroscopic assess-
ent is exploited in the correct projection using contrast
edium (Fig. 1).
Additional shunts should have been documented during
he pre-procedure transesophageal echocardiogram (TEE),
or which I concur with Hildick-Smith et al. (4), in seeing
necessity. During the procedure, additional small shunts
re likely to be missed, even when echocardiographic guid-
nce is used, unless they are in the PFO plane on which the
ltrasound imaging will be focusing.
The use of a few milliliters of contrast medium should not
ose a problem in any patient. A rare circumstance, such as
n urgent need for PFO closure in early pregnancy, may
mpose PFO closure exclusively (5) or almost exclusively (6)
uided by ultrasound.
The sharing of responsibility at the crucial moment of
evice release from the implantation gear is an important
eature in the beginning of the learning curve of an operator.
owever, the second opinion from the echocardiographer is
f little value, if he or she is also inexperienced, which is
sually the case in an institution embarking on PFO closure.
or a rookie operator in an experienced institution, the
dvice of a PFO-savvy interventional cardiologist is usually
vailable.
The arguments against using ultrasound guidance appear
ore compelling. To avoid undue inconvenience and risk to
he patient, intubation and general anesthesia is usually
Table 1. Arguments for and Against Ultrasound Guidance During
PFO Closure
For
Additional imaging technique to avoid suboptimal placement or device
embolization
Reduced risk of missing additional shunts
Immediate information about tightness
No need for contrast medium injections
Sharing of responsibility among two physicians
Against
Signiﬁcant prolongation of procedure engendering additional risks of
thrombosis or air embolism
Transesophageal echocardiography
Need for intubation and general anesthesia to avoid discomfort and
bronchial aspiration
In case of sedation only, discomfort and risk germane to esophageal
intubation in supine position
Intracardiac echocardiography
Second venous access (larger than the one required for PFO closure)
Additional intravascular and intracardiac manipulations not protected by a
guidewire
Cost of disposable probePFO patent foramen ovale.
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393onsidered a prerequisite for TEE guidance. This more than
riples the time of the intervention and generally requires a
hird physician in addition to the echocardiographer. Using
EE under simple sedation and local anesthesia is over-
hadowed by the risk of bronchial aspiration of saliva due to
he patient being in the supine position.
The use of intracardiac echocardiography (ICE) also
rolongs the procedure significantly but it does not neces-
arily require an additional physician. However, introducing
he ICE probe (not wire-guided) is a fairly rough act with at
east a doubled risk of puncture site problems and cardiac
erforation. A single operator gets distracted by trying to
eep the ICE probe properly directed while also handling
he device closure equipment. Moreover, the additional
xpense of approximately U.S. $2,000 is to be considered.
There are 2 major prerequisites to turn PFO closure into
hat could come close to a mechanical vaccination accept-
ble for all people with a PFO (approximately 25% of the
eneral population) or at least those with a dangerous
ariation of it (approximately 4%), in whom the 2 septa are
arely touching and the septum primum is extremely mobile
nd flimsy, which is usually referred to as atrial septal
neurysm.
First, it has to be efficient and safe. A complete closure
ate of 100% will never be achieved but, with the current
echnology of choice (3), a significant and “unfiltered”
unimpeded by the implanted device) residual shunt persists
n 5% of patients. A second device can remedy those 5%
ith a second intervention even more swiftly than the initial
ne. Safety is at least comparable with what is usually
Figure 1. Angiographic Aspect of a 25-mm Amplatzer PFO Occluder Before
Provided a correct view is chosen depicting the 2 disks in perfect proﬁle witho
tion of the device can be unequivocally ascertained before (left) and documen
lar septum secundum (SS), whereas the septum primum (SP) is thin, wraps aro
pusher cable), and extends from the lower rim after release. The dashed arrow
ing the PFO at its very top (top of arrow) is explained by the fact that the PF
low in either mouth angle. PFO  patent foramen ovale.ccepted for a vaccine. The only procedure compli-ation, occurring at a rate approaching 1%, is an arterio-
enous fistula at the groin. This is clinically benign but may
eed local surgery. The dreaded bacterial infection of the
evice has been reported, but only in a couple of isolated
fter Release
y overlap (usually a left oblique projection with cranial tilt), the correct posi-
fter (right) release. The left halves of the disks are separated by the muscu-
he inferior rim of the device before release (device position tilted by the stiff
cates the actual PFO tunnel. The fact that the interdisk connector is not pass-
has to be pictured as a sad mouth with a device connector typically hanging
Table 2. Ischemic Stroke Classification (Revised)
Local arterial occlusion
Lacunar
Intracerebral
Vertebral
Internal carotid
Common carotid
Brachiocephalic
Arterial embolus
Plaque/ulcer/dissection
Intracerebral
Carotid
Vertebral
Brachiocephalic
Ascending aortic
Cardiac embolus from
Left ventricle
Left atrium
Left atrial appendage
Myxoma or other tumor
Vegetation (septic embolus)
Paradoxical embolus
Patent foramen ovale
Atrial septal defect
Pulmonary ﬁstula
Pulmonary venous bed embolusand A
ut an
ted a
und t
indi
O slitCryptogenic
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394ases in the world literature. Even assuming underreporting,
hese cases have to be seen against the background of
evices having been implanted for PFO closure worldwide
n more than 100,000 people. The same holds true for
rosion of a free atrial wall by the device. This has been
eported in only 2 of more than 50,000 people having been
tted with an Amplatzer PFO occluder (AGA Medical,
orth Plymouth, Minnesota). Such an incidence of an
dmittedly severe side effect is indeed comparable with the
evere side effects of recommended vaccinations against
hildhood diseases. The second prerequisite is that the
ntervention is simple and this forfeits the use of ultrasound
uidance.
Before we can convince people that the general popula-
ion might need vaccination against a disease, they have to
e convinced that the disease needs prevention. The current
isclassification of strokes mediated by the PFO as an
ntity only to be considered after excluding all other
schemic stroke causes (after the establishment of the
iagnosis of cryptogenic [unexplained] stroke) needs to be
evised. The PFO can be the cause of an ischemic stroke
ith and without the presence of other acknowledged
schemic stroke reasons (Table 2). The term cryptogenic has
o be pushed beyond the PFO and perhaps even beyond the
mbolism from a clot originating form the pulmonary
enous bed, a mystic medical black box, the discussion of
hich is beyond the scope of these remarks. eeprint requests and correspondence: Dr. Bernhard Meier,
rofessor and Chairman of Cardiology, Cardiovascular Depart-
ent, University Hospital, 3010 Bern, Switzerland. E-mail:
ernhard.meier@insel.ch.
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